Shares of Canada House Wellness Group Inc. (CSE:CHV, OTC: SARSF, Forum) jumped higher at Monday’s open when it announced this that its wholly owned subsidiary, Abba Medix Corp., signed a medical cannabis supply agreement with Franchise Cannabis Corp.’s wholly owned German subsidiary ACA Müller ADAG Pharma Vertriebs GmbH for the Supply of Products to the European Union.
To find out more about this news, click here.
This comes on the heels of the last announcement from the Company, who stated last week that Abba Medix signed an exclusive licensing agreement with California-based SCM Tech, to bring its leading Santa Cruz Medicinals brand of CBD infused health care product lines to Canadian consumers. Under the deal, Abba Medix will license its intellectual property, including formulations, manufacturing techniques, trademarks, and marketing materials for the Canadian marketplace.
FULL DISCLOSURE: Canada House Wellness Group Inc. is a client of Stockhouse Publishing.